Physician profile
Ellen Tracy
NPI 1760005367
$1,550.28
in general payments reported to CMS, 2019-2025
17 companies · $981 in 2025
The $981 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $570 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,550.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $251.82 | 2024-2025 | Repatha, Otezla |
| Axsome Therapeutics, INC. | $208.46 | 2025 | Symbravo |
| Lilly USA, LLC | $167.88 | 2024-2025 | Mounjaro, Zepbound |
| Gilead Sciences, INC. | $135.00 | 2025 | Yeztugo |
| Abbvie INC. | $122.78 | 2025 | |
| Inspire Medical Systems, INC. | $120.54 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.85 | 2024 | Jardiance |
| Viiv Healthcare Company | $108.29 | 2024-2025 | Apretude |
| Merck Sharp & Dohme LLC | $86.75 | 2024 | Capvaxive |
| Novo Nordisk INC | $59.87 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $50.29 | 2024-2025 | Breztri, Farxiga |
| Exact Sciences Corporation | $34.01 | 2024-2025 | Cologuard Collection Kit |
| Harmony Biosciences LLC | $25.60 | 2024 | |
| Alkermes, INC. | $23.64 | 2024 | Vivitrol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.06 | 2025 | Xifaxan |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $14.76 | 2024 | Paradise Renal Denervation System |
| Azurity Pharmaceuticals, INC. | $14.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Tracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.